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Thio–ether bonds in the cysteinyl side chain of peptides, formed with the most commonly
used cysteine blocking reagent iodoacetamide, after conversion to sulfoxide, releases a neutral
fragment mass in a low-energy MS/MS experiment in the gas phase of the mass spectrometer
[6]. In this study, we show that the neutral loss fragments produced from the mono-oxidized
thio–ether bonds (sulfoxide) in peptides, formed by alkyl halide or double-bond containing
cysteine blocking reagents are different under low-energy MS/MS conditions. We have evaluated
the low-energy fragmentation patterns of mono-oxidized modified peptides with different cysteine
blocking reagents, such as iodoacetamide, 3-maleimidopropionic acid, and 4-vinylpyridine using
FTICR-MS. We propose that the mechanisms of gas-phase fragmentation of mono-oxidized
thio–ether bonds in the side chain of peptides, formed by iodoacetamide and double-bond
containing cysteine blocking reagents, maleimide and vinylpyridine, are different because of the
availability of acidic -hydrogens in these compounds. Moreover, we investigated the fragmen-
tation characteristics of mono-oxidized thio–ether bonds within the peptide sequence to develop
novel mass-spectrometry identifiable chemical cross-linkers. This methionine type of oxidized
thio–ether bond within the peptide sequence did not show anticipated low-energy fragmentation.
Electron capture dissociation (ECD) of the side chain thio–ether bond containing oxidized peptides
was also studied. ECD spectra of the oxidized peptides showed a greater extent of peptide
backbone cleavage, compared with CID spectra. This fragmentation information is critical to
researchers for accurate data analysis of this undesired modification in proteomics research, as well
as other methods that may utilize sulfoxide derivatives. (J Am Soc Mass Spectrom 2007, 18,
493–501) © 2007 American Society for Mass SpectrometryIn conventional or bottom-up proteomics research,proteins are commonly digested with trypsin andanalyzed by mass spectrometry [1]. Before diges-
tion, the disulfide bonds in the proteins are first cleaved
with either DTT or -mercaptoethanol, and their refor-
mation must be blocked using different cysteine block-
ing reagents. Several cysteine-blocking reagents exist;
the most common are iodoacetamide, N-ethylmaleimide,
acrylamide, and 4-vinylpyridine [2–4]. These methods
that use iodoacetamide rely on an alkyl halide to react
with the sulfhydryl group of cysteine. The other three
blocking reagents, maleimide, acrylamide, and vi-
nylpyridine utilize double bonds to react with the
sulfhydryl group of cysteine by the Michael addition
type mechanism [5]. All of these blocking reagents form
thio–ether bonds in the cysteinyl side chain of proteins.
Steen et al. reported that these thio–ether bonds can be
oxidized in current protein profiling techniques, such
as tryptic digestion and gel electrophoresis [6]. The
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doi:10.1016/j.jasms.2006.10.019oxidized thio–ether bond formed with iodoacetamide
in the cysteinyl side chain of the peptide loses a neutral
fragment mass in the gas phase under low-energy
MS/MS conditions. Steen et al. exploited this low-energy
fragmentation characteristic of mono-oxidized thio–ethers
to profile phosphorylation by -elimination and Michael
addition chemical strategy [7]. It was reported that this
characteristic neutral loss was generated by the formation
of dehydroalanine in a cysteinyl residue after releasing a
sulfenic acid fragment (RSOH, where R stands for added
tag mass from the blocking reagent) from the modified
peptide in a low-energy MS/MS experiment.
This study was carried out to investigate new fea-
tures for novel low-energy mass spectrometry cleavable
cross linkers where bonds can be selectively dissociate
with low-energy MS/MS in the gas-phase environment
of a mass spectrometer [8, 9]. Low-energy fragmenta-
tion characteristics of oxidized thio–ether bonds have
been reported [6, 7]. While incorporating this bond to
develop novel mass spectrometry cleavable PIR-cross
linkers, we have observed different low-energy frag-
mentation behavior for mono-oxidized thio–ether
bonds formed from different sulfhydryl reactive func-
tional groups.
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494 CHOWDHURY ET AL. J Am Soc Mass Spectrom 2007, 18, 493–501In this article, we show that the characteristic low-
energy fragment loss for mono-oxidized thio–ether
bonds in peptides is different if they are formed with
double bonds-containing cysteine blocking reagents.
These results show that the gas-phase fragmentation
pathways for mono-oxidized thio–ether bond in the
side chain of the peptide are different for different
sulfhydryl reactive blocking reagents. We propose that
due to the availability of additional acidic -hydrogens
in the double bond-containing cysteine blocking reagents,
the mono-oxidized thio–ether residues fragment differ-
ently in the gas-phase environment of a mass spectrom-
eter. We have also incorporated a methionine-like thio–
ether bond within a peptide sequence to validate the
feasibility of constructing a novel mass spectrometry
cleavable cross-linker. The low-energy MS/MS of pep-
tide containing thio–ether bond within the sequence
was compared with its oxidized counterpart. The inter-
nal oxidized thio–ether containing peptide did not
show any low-energy fragmentation. The ECD spectra
of this modification also show different fragmentation
patterns as compared with low-energy CID spectra.
Experimental
Iodoacetamide, 3-maleimidopropionic acid and 4-
vinylpyridine were purchased from Sigma-Aldrich
(St. Louis, MO). The 30% H2O2 solution was also
purchased from Sigma-Aldrich. Cysteinyl peptides SE-
VAHRFKC and CHWKQNDEQM were synthesized in
Washington State University peptide synthesis facility
with an Applied Biosystems 431-A (Foster City, CA)
peptide synthesizer. The sulfhydryl group of cysteine in
the peptides was blocked with different sulfhydryl
reactive reagents in presence of the NH4HCO3 or PBS
buffer. The selective mono-oxidation of sulfur in the
thio–ether was accomplished by reacting the peptide in
a 3% H2O2 solution for 15 min. Desalting was accom-
plished with ZipTip (Millipore, Billerica, MA) and Sep-
Pack C18 (Water, Milford, MA) purification.
All FTICR-MS spectra were obtained with a Bruker
Daltonics 7T APEX Q-FTICR mass spectrometer (Bil-
lerica, MA) by direct infusion of samples with a nano
ESI source made with fused silica capillary (360 um o.d
and 20 um i.d). The capillary tip was etched with 49%
HF. The FTICR mass spectra were processed with the
software, ICR-2LS, developed by Pacific Northwest
National Laboratory (PNNL) [10]. CID mass spectra
were calibrated externally utilizing standard peptides,
Substance P (RPKPQQFFGLM), Bradykinin (RPPGFS-
RFR), and the peptide SEVAHRFKC. The electrospray
solution was MeOH/H2O/AcOH (49:49:2) unless oth-
erwise mentioned. Electron capture dissociation was
performed using a heated hollow cathode dispenser
located outside the ICR cell to obtain the MS/MS data.
The cathode dispenser was heated gradually to 1.8 to
1.9 A. Side kick trapping voltage [11] was maintained
between 6 V to 6 V. Electrons used for ECD were
accelerated with 3 V. The electron injection time was200 ms. ECD spectra were calibrated externally with a
standard peptide, Substance P.
Synthesis of the Internal Thio–Ether
Bond-Containing Peptide
The peptide containing an internal thio–ether bond was
synthesized using an ABI 431-A peptide synthesizer
(Applied Biosystems) utilizing typical Fmoc peptide
synthesis cycles except the thio–ether bond was intro-
duced by the reaction with 2-amino-ethanethiol (Aldrich,
St. Louis, Mo) with bromoacetic acid (Aldrich). Bro-
moacetic acid was coupled to the alanine residue of the
peptide, ALVG, using standard Fmoc cycles. Next, solid
cysteamine HCl (2-amino-ethanethiol) was added di-
rectly to the reaction vessel that contains NMP solvent,
0.1 mL of 1.0 M dimethylaminopyridine/N,N dimeth-
ylformamide (Applied Biosystems) and 0.1 mL water.
This condition was used to increase the reaction rate by
deprotonating the thiol group. The primary amine
group of the cysteamine attached peptide was further
coupled with phenylalanine residue of a small peptide,
LVF, using same Fmoc chemistry. The final product
was dried under vacuum. ESI-FTICR-MS analysis re-
veals the purity of the peptide product was about 50%.
No further purification was done on the peptide prod-
uct. Selective oxidation of sulfur in the thio–ether bond
was achieved by reacting the peptide product with 3%
H2O2 solution for 15 min.
Results and Discussion
Our study was carried out with two peptides, which
have cysteine residues situated at the N-terminal and
C-terminal sites of peptides. We first carried out experi-
ment with a cysteine-containing peptide (SEVAHRFKC).
The peptide was reacted with iodoacetamide to form a
carbamidomethyl modification on the sulfhydryl group
of cysteine, a common procedure in proteomics re-
search to block free thiols. After selective oxidation of
the thio–ether bond, desalting, and vacuum drying, the
sample was reconstituted in MeOH:H2O:AcOH (49:49:2)
for ESI-FTICR-MS analysis. To observe the fragmenta-
tion characteristics of oxidized and modified peptides
in FTICR-MS, the solutions were sprayed with a nano-
electrospray source with 20 L/h flow rate. Ions at m/z
575.2794 correspond to the expected [M  2H]2 ion of
the oxidized iodoacetamide-labeled peptide and were
isolated in the quadrupole (Figure 1a), (Table 1). The
ions were then fragmented in the hexapole by increas-
ing the collisional trap voltage by three increments
(Figure 1b, c, d). At 6 V the characteristic low-energy
signature ion at m/z 521.7770 appeared with high inten-
sity in the spectra after the predicted neutral loss of
RSOH fragment (R  58.0292 Da) (Figure 1b). The
expected accurate mass of this neutral fragment, RSOH
(C2H5NO2S) was 107.0042 Da. We observed the neutral
loss of 107.0048 Da from the low-energy MS/MS exper-
9 V
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107.0048 Da) in FTICR-MS with a mass error of 0.7 mDa
(Table 1). At 9 V this ion, m/z 521.7770, appeared in
the spectrum with high intensity. No significant peptide
backbone fragments were generated at this collisional
trap voltage other than the fragment generated after
loss of RSOH from the side chain of the modified
peptide. Increasing the voltage settings (12 V) in-
creased the intensity of m/z 521.7770 (Figure 1d). This
confirms the low-energy fragmentation characteristic of
a side chain mono-oxidized iodoacetamide labeled pep-
tide as previously reported by Steen et al., using a
q-TOF instrument [6].
To determine if this characteristic sulfenic acid frag-
ment loss (RSOH) from the side chain mono-oxidized
thio– ether residues in peptides is common among
other cysteine blocking reagents, we studied fragmen-
tation characteristics with two other commonly used
reagents. We first studied the fragmentation character-
istics of the same cysteinyl peptide (SEVAHRFKC)
modified with a maleimide group. Maleimide contains
an unsaturated bond which reacts with the sulfhydryl
group of cysteine by a Michael addition type reaction
mechanism. The peptide SEVAHRFKC was reacted
with 3-maleimidopropionic acid under the same condi-
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Figure 1. Low energy ESI-FTICR-MS/MS spec
labeled with iodoacetamide. The sulfur in the si
by oxidation. The ions at m/z 575.2794, correspon
and were isolated in the quadrupole and subject
spectra shown were acquired with 1 V, 6 V,tions we utilized for iodoacetamide reaction. The sulfurin the newly formed thio–ether bond was then oxidized
as previously described. The ions observed at m/z 
631.2848 correspond to [M  2H]2 ions of the oxidized
maleimide-modified peptide and were isolated in the
quadrupole and subjected to increased collisional trap
voltage (Figure 2a, b, c), (Table 1). Two fragment ions
appeared in the spectra at m/z 537.7613 and m/z
521.7758. The intensity of the ion at m/z 537.7613 in-
creased with increasing collisional trap voltage (Figure
2b, c). The expected low-energy fragment ion (i.e., loss
of RSOH) at m/z 521.7758 appeared in the spectra at a
very low intensity using low collisional trap voltages
and did not increase with increased voltages. The ions
at m/z 537.7613 appeared as the dominant peak at 15
V due to the fragmentation of the molecular peak but no
significant peptide backbone cleavage was observed.
These data show that the low-energy fragmentation
characteristics of iodoacetamide and maleimide-labeled
mono-oxidized thio–ether residues in the same peptide
sequence are different. In this case, low-energy frag-
ment ions correspond to a neutral fragment loss of R 
H2O from the oxidized modified peptide (R  MW of
3-maleimidopropionic acid) were observed. The accu-
rate mass for the loss of R  H2O is 187.0480 Da. We
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(Table 1).
To see if this neutral loss is specific for maleimide
modified peptides, we reacted the same peptide with
another cysteine labeling reagent, 4-vinylpyridine. The
4-vinylpyridine has the same double-bond functional
group, but has asymmetry around the double-bond.
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Table 1. List of m/z values and calculated neutral and observed
Neutral masses
in Da Expect
Peptide-1 SEVAHRFKC 1075.5232 538.76
Peptide-2 CHWKQNDEQM 1317.5229 659.76
Peptide-2 (Ox) CHWKQNDEQM 1333.5178 —
Iodoacetamide (IA) [added mass] 58.0292 —
3-maleimidopropionic acid (MP) 169.0375 —
4-vinylpyridine (VP) 105.0578 —
Peptide-1  IA  [O] 1148.5395 1149.54
575.27
Peptide-1  MP  [O] 1260.5556 1261.56
631.28
Peptide-1  VP  [O] 1196.5759 1197.58
599.29
Peptide-2 (Ox)  MP  [O] 1518.5502 1519.55
760.28
RSOH (IA) 107.0041 —
R  H2O (MP) 187.0480 —
R  H2O (VP) 123.0683 —voltage settings. Mass spectra shown were acquired wThe observed ions at m/z 599.2939, which correspond to
[M  2H]2 ions of oxidized vinylpyridine-modified
peptides, were isolated in the quadrupole and the trap
voltage was increased as previously described (Figure 3)
(Table 1). Two fragment ions appeared in the spectra,
showing the same fragmentation as we observed for the
maleimide labeled peptide. The ions at m/z 537.7590,
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observed in the spectra and the intensity of these ions
increased with increasing collisional trap voltages
(Figure 3b, c, d). The characteristic ions, generated after
neutral loss of R  H2O, were also observed at 1
charge state in the spectra (m/z 1074.5105 Da). The ions
at m/z 521.7590, which correspond to the loss of the
expected neutral fragment mass from the peptide (loss
of RSOH) were also observed in the spectra but did not
show intensity changes after setting different voltages
in the collisional trap. These data showed that both
maleimide and vinylpyridine have similar low-energy
fragmentation characteristics for side chain mono-
oxidized thio–ether residues in peptides, which are the
neutral loss of the R  H2O fragment, not the loss of
RSOH as observed with iodoacetamide-modified pep-
tides. The accurate neutral mass for R  H2O of
vinylpyridine labeled peptide is 123.0683 Da. We ob-
served the neutral loss of 123.0698 Da with an error of
1.5 mDa (Table 1).
To confirm these characteristic losses with other pep-
tide sequences, we reacted the peptide CHWKQNDEQM
with 3-maleimidopropionic acid. The newly formed
thio–ether bond was selectively oxidized to sulfoxide.
The cysteine side chains blocked with iodoacetamide
and 3-maleimidopropionic acid were confirmed from
the MS/MS and ECD spectra of unoxidized iodoacet-
amide and maleimide labeled peptides. ECD study of
Figure 3. Low energy ESI-FTICR-MS/MS spe
labeled with 4-vinylpyridine. The sulfur in the si
by oxidation. The ions at m/z 599.2939 correspon
and were isolated in the quadrupole and subjec
spectra shown were acquired with 1 V, 6 V,unoxidized iodoacetamide derivatized peptide was re-ported by several authors [12, 13]. The ECD and CID of
corresponding unoxidized iodoacetamide-and maleimide-
labeled peptides confirmed the labeling on the cysteinyl
side chain of the peptides. The methionine residue in
the peptide CHWKQNDEQM was found to be mono-
oxidized after these modification reactions (Supplemen-
tary Material section, data 1, 2 which can be found in
the electronic version of this article). The ions at m/z
760.2837, which corresponds to [M  2H]2 ions of
modified and oxidized peptides, were isolated in the
quadrupole and fragmented in the hexapole (Figure 4a,
b, c, d,) (Table 1). The fragmentation spectra showed the
same neutral loss fragment behavior that we observed
with other peptides labeled with maleimide and vi-
nylpyridine. The ions at m/z 666.7595 (2) correspond
to the neutral loss of R  H2O from the methionine
oxidized vinylpyridine modified peptides. A competing
water loss fragment was also observed from the oxi-
dized peptide. Thus, neutral loss fragments observed
under low-energy CID conditions with peptides modi-
fied by double-bond containing cysteine reactive re-
agents, maleimide and vinylpyridine were primarily
R  H2O.
The side chains of cysteine residues of peptides
SEVAHRFKC were labeled with different cysteine
blocking reagents and they showed distinct low-energy
fragmentation in the gas phase in a mass spectrometer.
To determine, if a sulfoxide group within a peptide
of cysteine-containing peptides (SEVAHRFKC)
ain thio–ether residue is converted to sulfoxide
[M  2H]2 ions of oxidized modified peptides
o various collisional trap voltage settings. Mass
, and 12 V (a), (b), (c), (d).ctra
de ch
d to
ted tsequence would show similar low-energy fragmentation
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to the side chain of methionine within a peptide se-
quence. The low-energy fragmentation characteristic of
mono-oxidized methionine side chain residue (methio-
nine sulfoxide) was also reported [14–16]. Our studies
of mono-oxidized thio–ether bonds of methionine side
chains also showed low-energy fragmentation charac-
teristics, but did not show the same labile characteristics
as we observed for the side chains of mono-oxidized
thio–ether bonds of cysteine in peptides (Supplemen-
tary data 3). To compare the fragmentation characteristics
of the internal thio–ether bond-containing peptide, we
first selectively oxidized sulfur to sulfoxide. The
MS/MS of both peptides, oxidized and non-oxidized,
were obtained using 15 V collisional trap voltage
(Figure 5a, b). Both oxidized and nonoxidized peptides
showed similar fragmentation characteristics. Several
“b” ions were observed without any selective cleavage
in the thio–ether bond. These data suggest that within
peptide sequence, the methionine-like thio–ether resi-
dues fragment differently than the oxidized thio–ether
residue in the amino acid side chain.
To compare the ECD of these modified peptides with
that of CID, we first looked at the ECD of oxidized
cysteinyl peptide, SEVAHRFKC, blocked with iodoac-
Figure 4. Low energy ESI-FTICR-MS/MS spect
labeled with 3-maleimidopropionic acid. The su
to sulfoxide by oxidation. The ions at m/z 760
modified peptides and were isolated in the qu
voltage settings. Mass spectra shown were acqu
(d). The asterisk denotes noise peaks.etamide. We isolated [M  2H]2 ions in the quadru-pole and low-energy electrons were irradiated with
conditions mentioned previously in the experimental
section. We observed three distinct “c” ions, c6, c7, and
c8 in the spectrum (Figure 6). Since no such fragments
were observed with the addition of the modification
mass, these data strongly suggest the modification
exists on the C-terminal cysteine, as one might expect
for sulfhydryl-reactive compounds. Ions observed at
m/z  1149.57 correspond to [M  H] ion of this
modified peptide and were detected after electron irra-
diation. Ions at m/z  1091.57 were observed in the
spectrum and correspond to the loss of iodoacetamide
tag from the modified and oxidized peptide. Both ions
which correspond to [M (RH2O)] and [M RSOH]
were observed in this ECD spectrum.
The ECD of the maleimide-labeled oxidized cystei-
nyl peptide and iodoacetamide labeled oxidized pep-
tide SEVAHRFKC, showed similar fragmentation be-
havior. The m/z 631.28 corresponds to the [M 2H]2 of
ions of oxidized modified peptides; the ions were
isolated in the quadrupole, trapped in the ICR cell, and
were irradiated with electrons for 150 to 200 ms. Three
detected “c” ions (c6, c7, c8), were also observed for
iodoacetamide-labeled oxidized peptides. The ions at
m/z 1074.56 and m/z 537.78, which correspond to the
cysteine containing peptides (CHWKQNDEQM)
n the side chain thio–ether residue is converted
correspond to [M  2H]2 ions of oxidized
pole and subjected to different collisional trap
ith 3 V, 9 V, 12 V, and 15 V (a), (b), (c),ra of
lfur i
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ired wloss of ROH2 molecule from the oxidized modified
499J Am Soc Mass Spectrom 2007, 18, 493–501 MONO-OXIDIZED THIO–ETHER BONDS IN PEPTIDESFigure 5. ESI-FTICR-MS/MS spectra of peptide containing either oxidized or nonoxidized thio–
ether bonds within the sequence. (a) ESI-FTICR-MS/MS spectra of a peptide containing non-oxidized
thio-ether bond within the backbone of the sequence. At 15 V trap voltage few b-ions were
generated. No specific fragmentation occurred at non oxidized thio–ether bond. (b) ESI-FTICR-
MS/MS spectra of peptide containing mono-oxidized thio-ether bond inside the sequence. At 15 V
trap voltage, a similar fragmentation pattern was observed with the oxidized peptide.Figure 6. ECD-FTICR mass spectra of the peptide (SEVAHRFKC) reacted with iodoacetamide and
3-maleimidopropionic acid. The sulfur atoms in thio–ether bonds were converted to sulfoxide (See
Figures 1 and 2 for CID mass spectra). (a) ECD spectrum of unmodified peptide. (b) ECD spectrum
of mono-oxidized iodoacetamide labeled peptide. (c) ECD spectrum of mono-oxidized maleimide
labeled peptide. The number sign denotes modification and the asterisk denotes noise peaks.
500 CHOWDHURY ET AL. J Am Soc Mass Spectrom 2007, 18, 493–501peptide, were also observed. Ions at m/z  1091.57,
which corresponds to loss of maleimide tag from the
oxidized peptides, were observed in the spectrum.
The ECD spectra of both oxidized iodoacetamide and
maleimide-labeled mono-oxidized peptides showed sim-
ilar fragmentation patterns in FTICR-MS. These data
showed much more backbone cleavage than was ob-
served in the CID spectra. The difference in the ECD
spectra of iodoacetamide-labeled and maleimide-
labeled oxidized peptide is in the observation of
low-energy signature ions. In iodoacetamide labeled
oxidize peptides, we observed both [M  RSOH] and
[M  (R  H2O)] ions, whereas in maleimide labeled
peptides, we observed only [M  (R  H2O)] ions.
Gas-phase fragmentation of aliphatic and alicyclic
sulfoxides and sulphones with electron impact ioniza-
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- elimination of oxidized thio–ether bonds in peptide
side chain was proposed by Steen et al. [6]. The abstrac-
tion of an acidic -hydrogen from the peptide backbone
by the oxygen of thio–ether residues results in the
migration of a hydrogen and the loss of the iodoacet-
amide tag as sulfenic acid. This mechanism also results
in formation of a double-bond at the position of the
cysteinyl side chain of the peptide. For peptides labeled
with maleimide and vinylpyridine, two additional
acidic -hydrogens ( to carbonyl group, pKa  25) are
available in these groups besides the acidic -hydrogen
in the peptide backbone. The abstraction of -hydrogens
from these compounds generates a sulfenic-acid con-
taining peptide. These mechanisms are illustrated with
the maleimide group in Figure 7. Extreme instability of
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maleimide and vinylpyridine. Fragmentation pathways are shown with the 3-maleimidopropionic
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et al. [18]. The mass spectra of methane and ethane-
sulfenic acid was investigated by Turecek et al. [19]. The
CID mass spectrum of methanesulfenic acid showed the
loss of H2O from this molecule [19]. In our case, the
sulfenic acid-containing peptides readily lost water
molecules in the gas phase to generate more stable
sulfide, which results in the appearance of [M  (R 
H2O)] ion in the spectra following the loss of the
maleimide tag and a water molecule. In another path-
way, the abstraction of a -hydrogen from the peptide
backbone causes the migration of sulfenic acid in the tag
and the loss of RSOH fragment from the peptide. Both
pathways were observed for maleimide and vinylpyri-
dine but the abstraction of a -hydrogen from the
maleimide and vinylpyridine rather than the peptide
backbone appears more favorable. For peptides con-
taining a mono-oxidized thio–ether residue within the
sequence, two -hydrogens are present near the sulfox-
ide group. Abstraction of these hydrogens (pKa  45 to
50) and formation of an unsaturated bond is not favor-
able. Therefore, we did not observe characteristics low-
energy fragmentation behavior for this internal oxi-
dized thio–ether containing peptide.
Conclusions
In this study, we report low-energy neutral fragmenta-
tion of side chain mono-oxidized thio–ether bonds in
peptides and differences observed with various cysteine-
blocking reagents. The mono-oxidized thio–ether
bonds formed with commonly used iodoacetamide or
double bond-containing cysteine reactive reagents,
showed different neutral fragment loss in the gas-phase
environment of the mass spectrometer. We also report
that these mono-oxidized thio–ether bonds showed
low-energy fragmentation characteristics that appear to
depend upon the availability of acidic -hydrogens. On
the other hand, the methionine-like mono-oxidized
thio–ether bond within the peptide sequence did not
show any low-energy fragmentation behavior. The ECD
spectra of this peptide showed more backbone cleavage
and sequence info than observed in the corresponding
CID spectra. We believe this information is very impor-
tant for proteomics research because alkyl halides and
Michael acceptors containing acidic hydrogens are com-
monly used functional groups to block cysteines in
proteins. Therefore, fragmentation characteristics of this
undesired modification must be understood and imple-
mented in the search algorithms for accurate data
analysis in proteomics research. Some time ago, thio–
ether modifications were also discovered in the internal
sequence of some peptide antibiotics, called lantibiotics
[20], as is more recently discussed [21]. We feel the
fragmentation study of the oxidized thio–ether in the
internal sequence may also assist in that lantibioticresearch area. Finally, better understanding of the low-
energy fragmentation behavior of this sulfoxide group
can aid in the development of a new class of mass
spectrometry cleavable chemical reagents.
Acknowledgments
This research was supported by the Office of Science, Biological
and Environmental Research (BER), U.S. Department of Energy,
grant no. DE-FG02-04ER63924, and The Murdock Charitable trust.
The authors thank Gordon A. Anderson for the data analysis tools
used for this research.
References
1. Bogdanov, B.; Smith, R. D. Proteomics by FTICR Mass Spectrometry:
Top Down and Bottom Up. Mass Spectrom. Rev. 2005, 24, 168–200.
2. Sechi, S.; Chait, B. T. Modification of Cysteine Residues by Alkylation.
A Tool in Peptide Mapping and Protein Identification. Anal. Chem. 1998,
70, 5150–5158.
3. Schilling, B.; Yoo, C. B.; Collins, C. J.; Gibson, B. W. Determining
Cysteine Oxidation Status Using Differential Alkylation. Int. J. Mass
Spectrom. 2004, 236, 117–127.
4. Fullmer, C. S. Identification of Cysteine-Containing Peptides in Protein
Digests by High-Performance Liquid Chromatography. Anal. Biochem.
1984, 142, 336–339.
5. March, J. Advance Organic Chemistry Reactions, Mechanisms and Structure,
4th ed. New York: John Wiley & Sons, Inc. 1999, p 795-797.
6. Steen, H.; Mann, M. Similarity Between Condensed Phase and Gas
Phase Chemistry: Fragmentation of Peptides Containing Oxidized
Cysteine Residues and Its Implications for Proteomics. J. Am. Soc. Mass
Spectrom. 2001, 12, 228–232.
7. Steen, H.; Mann, M. A New Derivatization Strategy for the Analysis of
Phosphopeptides by Precursor Ion Scanning in Positive Ion Mode.
J. Am. Soc. Mass Spectrom. 2002, 13, 996–1003.
8. Anderson, G. A.; Bruce, J. E., Eds; ICR-2LS; Pacific Northwest National
Laboratory: Richland, WA, 1995.
9. Tang, X.; Munske, G. R.; Siems, W. F.; Bruce, J. E. Mass Spectrometry
Identifiable Cross-Linking Strategy for Studying Protein-Protein Inter-
actions. Anal. Chem. 2005, 77, 311–318.
10. Chowdhury, S. M.; Munske, G. R.; Tang, X.; Bruce, J. E. CAD, ECD, of
Several Mass Spectrometry-Identifiable Chemical Cross-Linkers. Anal.
Chem. in press.
11. Caravatti, P.; Allemann, M. The “Infinity Cell”: A New Trapped-Ion
Cell with Radiofrequency Covered Trapping Electrodes for Fourier
Transform Ion Cyclotron Resonance Mass Spectrometry. Org. Mass
Spectrom. 1991, 26, 514–518.
12. Mormann, M.; Macˇek, B.; De Peredo, A. G.; Hofsteenge, J.; Peter-
Katalinic´, J. Structural Studies on Protein O-Fucosylation by Electron
Capture Dissociation. Int. J. Mass Spectrom. 2004, 234, 11–21.
13. Adamson, J. T.; Håkansson, K. Infrared Multiphoton Dissociation and
Electron Capture Dissociation of High-Mannose Type Glycopep-
tides. J. Proteome Res. 2006, 5, 493–501.
14. Galeva, N. A.; Esch, S. W.; Williams, T. D.; Markille, L. M.; Squier, T. C.
Rapid Method for Quantifying the Extent of Methionine Oxidation in
Intact Calmodulin. J. Am. Soc. Mass Spectrom. 2005, 16, 1470–80.
15. Reid, G. E.; Roberts, K. D.; Kapp, E. A.; Simpson, R. I. Statistical and
Mechanistic Approaches to Understanding the Gas-Phase Fragmenta-
tion Behavior of Methionine Sulfoxide Containing Peptides. J. Proteome
Res. 2004, 3, 751–759.
16. Guan, Z.; Yates, N. A.; Bakhtiar, R. Detection and Characterization of
Methionine Oxidation in Peptides by Collision-Induced Dissociation
and Electron Capture Dissociation. J. Am. Soc. Mass Spectrom. 2003, 14,
605–613.
17. Smakman, R.; Boer, D. J. T. The Mass Spectra of Some Aliphatic and
Alicyclic Sulphoxides and Sulphones. Org. Mass Spectrom. 1970, 3,
1561–1588.
18. Lacombe, S.; Banchereau, M. L. E.; Simon, M.; Pfister-Guillouzo, G.
Sulfenic Acids in the Gas Phase: A Photoelectron Study. J. Am. Chem.
Soc. 1996, 118, 1131–1138.
19. Turecek, F.; Drinkwater, D. E.; McLafferty, F. W. Gas-Phase Chemistry
of CH3SOH,
CH2SHOH, CH3SO
·, and CH2SOH by Neutralization-
Reionization Mass Spectrometry. J. Am. Chem. Soc. 1989, 111, 7696–7701.
20. Gross, E.; Morell, J. L. Structure of Niacin. J. Am. Chem. Soc. 1971, 93,
4634–4635.
21. Xie, L.; Van Der. Donk, W. A. Post-Translational Modifications During
Lantibiotic Biosynthesis. Curr. Opin. Chem. Biol. 2004, 8, 498–507.
